Skip to main content
. 2021 Aug 5;59:314–320. doi: 10.1016/j.breast.2021.08.003

Table 2.

Description of surgical management in study populationa.

Total
N = 6926
Low nSES
N = 2381 (34.4)
Middle nSES
N = 2324 (33.5)
High nSES
N = 2221 (32.1)
P-value
Surgery Type 0.028
BCSb 1993 (28.8) 650 (27.3) 659 (28.4) 684 (30.8)
Mastectomy 4933 (71.2) 1731 (72.7) 1665 (71.6) 1537 (69.2)
BCTc 0.029
No/Unknown 1085 (54.4) 378 (58.2) 335 (50.8) 372 (54.4)
Yes 908 (45.6) 272 (41.8) 324 (49.2) 312 (45.6)
Mastectomy-Radiation 0.150
None/Unknown 2772 (56.2) 1004 (58.0) 913 (54.8) 855 (55.6)
Yes 2161 (43.8) 727 (42.0) 752 (45.2) 682 (44.4)
Reconstruction <0.001
No 4200 (85.1) 1592 (92.0) 1412 (84.8) 1196 (77.8)
Yes 733 (14.9) 139 (8.0) 253 (15.2) 341 (22.2)
BCS-lymph node Surgeryd 0.004
No 771 (39.7) 285 (44.9) 232 (36.5) 254 (37.7)
Yes 1173 (60.3) 350 (55.1) 404 (63.5) 419 (62.3)
Mastectomy-lymph node surgerye 0.890
No 867 (18.1) 302 (18.1) 298 (18.4) 267 (17.7)
Yes 3924 (81.9) 1364 (81.9) 1322 (81.6) 1238 (82.3)
a

Datapoints reported as n (%) unless specified otherwise. Data may not add up to 100 % due to rounding.

b

Breast Conservation Surgery (BCS).

c

Breast Conservation therapy (BCS + radiation).

d

This data point only includes patients who underwent breast conservation surgery.

e

This data point only includes patients who underwent mastectomy.